Abbott completed aquisition of St Jude Medical Valued at $25 billion
On Jan. 4, 2017, Abbott announced it had completed the acquisition of St. Jude Medical, establishing the company…
Abbott completed acquisition of St Jude Medical for $25 billion
On Jan. 4, 2017, Abbott announced it had completed the acquisition of St. Jude Medical for $25 billion….
First drug approved by the FDA for treatment of canine lymphoma
On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…
BioXcel therapeutics was founded
In 2017, BioXcel Therapeutics was founded in New Haven, Connecticut as a clinical-stage biopharmaceutical company that utilizes novel…
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
Biotechnology | Life Science History | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
Genomic sequencing illuminated Shigella outbreaks in California
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health announced…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Medigen Vaccines Biologics teamed with U.S. CDC to develop VLP vaccine for Dengue disease
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Therapeutics | Women's Health
The U.S. Surgeon General issued landmark Report on Alcohol, Drugs, and Health
On Nov. 17, 2016, the U.S. Surgeon General Dr. Vivek Murthy issued a landmark Report on Alcohol, Drugs,…
Biotechnology | CRISPR | Disease | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics
The National Institutes of Health issued guidelines for DNA splicing
On Nov. 15, 2016, the National Institutes of Health (NIH) issued guidelines for DNA splicing. The guidelines set…
Fred Hutch opened first-of-its kind Bezos Family Immunotherapy Clinic
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
Biotechnology | Chemical | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
UO launched $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact
On Oct. 18, 2016, the University of Oregon (UO) announced the $1 billion Phil and Penny Knight Campus…
$10 million gift created Bursky Center for Human Immunology and Immunotherapy
On Sept. 26, 2016, Washington University School of Medicine in St. Louis announced it had received a $10…
New prostate cancer therapy investigated at Vanderbilt University Medical Center
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
Thermo Fisher Scientific completed its acquisition of FEI Company
On Sept. 19, 2016, Thermo Fisher announced it had completed its acquisition of FEI Company for a total…
Bayer and Monsanto announced merger
On Sept. 14, 2016, Bayer and Monsanto announced a merger agreement whereby Bayer acquired Monsanto for USD $128…
University of Washington Medicine performed region’s 1st adult intestineï¾ transplant
On Sept. 11, 2016, the University of Washington Medicine (UW) announced that a medical team became the first…
UAlberta received $82.5 million research infrastructure boost from federal government and province
On Sept. 8, 2016, the University of Alberta received $82.5 million in infrastructure funding from the federal and…
Danaher acquired Cepheid for $53.00 per share, or approximately $4 billion
On Sept. 6, 2016, Danaher announced a merger agreement with Cepheid pursuant to which Danaher acquired all of…
Agriculture | Biotechnology | Diagnostics | Disease | Energy | Life Science News | Medical Device | Therapeutics
State Senator Pat Steadman honored by University of Colorado Cancer Center
On Aug. 31, 2016, State Senator Pat Steadman was honored by the University of Colorado Cancer Center (CU)…
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
UNMC opened new home for College of Pharmacy
On Aug. 23, 2016, University of Nebraska Medical Center (UNMC) celebrated the grand opening of the UNMC Center…
Siteman Cancer Center received a $10.4 million grant from the NCI
On Aug. 15, 2016, Siteman Cancer Center received a $10.4 million five-year grant to Washington University researchers and…
The National Institutes of Health awarded $28.3 million to Jackson Laboratory for Knockout Mouse Production and Phenotyping Project
On Aug. 4, 2016, the National Institutes of Health (NIH) awarded a total of $28.3 million to The…
Southwest National Primate Research Center at Texas Biomed received $40 million NIH grant
On Aug. 4, 2016, the Southwest National Primate Research Center at Texas Biomedical Research Institute was awarded more…
SERM drug raloxifene (Evista) found to reduce breast cancer risk for postmenopausal women
On Jul. 17, 2006, the SERM drug raloxifene (Evista) was found to reduce breast cancer risk for postmenopausal…